Company Profiles

driven by the PitchBook Platform

Altravax

Description

Developer of immunogen optimization vaccines designed to improve human health, individually and globally, by preventing and treating diseases. The company's immunogen optimization vaccines uses proprietary immunogen optimization system that offers unique opportunities to create novel vaccines or improve currently available alternatives to fill unmet medical needs, enabling patients to fight infectious diseases or treat other harmful indications.

2009

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$4.65M

Latest Deal Amount

$2.01M

Total Amount Raised

Description

Developer of immunogen optimization vaccines designed to improve human health, individually and globally, by preventing and treating diseases. The company's immunogen optimization vaccines uses proprietary immunogen optimization system that offers unique opportunities to create novel vaccines or improve currently available alternatives to fill unmet medical needs, enabling patients to fight infectious diseases or treat other harmful indications.

Website:

www.altravax.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

725 San Aleso Avenue Suite 2 Sunnyvale, CA 94085United States +1 (888) 710-9203
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Altravax's full profile, request a free trial.

Altravax Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Altravax Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Arthur VenturesVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
US Government's Qualifying Therapeutic Discovery ProjectOther000 0000000 0000
Arthur Ventures Venture Capital
National Institutes of Health Government
US Government's Qualifying Therapeutic Discovery Project Other

Altravax Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Robert WhalenChief Scientific Officer, Board Member & Co-Founder
Janelle MuranakaDirector, Operations
Michael ChambersCo-Founder, Board Member, President and Interim Chief Executive Officer
Robert Whalen Chief Scientific Officer, Board Member & Co-Founder
Janelle Muranaka Director, Operations
Michael Chambers Co-Founder, Board Member, President and Interim Chief Executive Officer

Altravax Board Members (5)

NameRepresentingRoleSinceContact
Info
James BurgumArthur VenturesCo-Founder & Managing Partner000 0000
Leonard Ruiz Ph.DAltravaxBoard Member000 0000
Michael ChambersSelfCo-Founder, Board Member, President and Interim Chief Executive Officer000 0000
Robert WhalenAltravaxChief Scientific Officer, Board Member & Co-Founder000 0000
Ron BerganSelfBoard Member000 0000
James Burgum Co-Founder & Managing Partner Arthur Ventures
Leonard Ruiz Ph.D Board Member Altravax
Michael Chambers Co-Founder, Board Member, President and Interim Chief Executive Officer Self
Robert Whalen Chief Scientific Officer, Board Member & Co-Founder Altravax
Ron Bergan Board Member Self
Request full access to PitchBook